Dr. Keshav Malhotra visits SpOvum

Dr. Keshav Malhotra MBBS. MCE holds a Masters’s degree in Clinical Embryology from Monash university Australia and is one of the few ESHRE-certified Clinical Embryologists from INDIA. He is the Lab Director of Rainbow IVF and now the Director of Malhotra Embryology Training Academy. Dr. Malhotra is the Co-chair of SIG Embryology for ASPIRE (Asia Pacific Initiative on Reproduction), and he is also on the executive board of ISAR(Indian Society of Assisted Reproduction) and ISPAT(Indian Society for Prenatal Diagnosis and Therapy). He has worked on Key projects pertaining to Embryology in India like the Occupational Standard for Embryologists (Healthcare Sector Skill Council India-2018) and the ISAR – Embryology Consensus 2019. He was recognized as Budding Embryologist of the Year by Economic Times INDIA -2019.

SpOvum® got an opportunity to present its product portfolio to Dr. Keshav Malhotra, who visited SpOvum on 16th Dec 2022. He was fascinated by the RoboICSI workbench especially the one-click sperm immobilization feature of the RoboICSI workbench. Dr. Keshav was really excited when he tried out using the button-based controller and the one-click immobilization feature by himself.

Dr. Keshav Malhotra with Founder Directors of SpOvum

Dr. Keshav appreciated the stiffness estimation experiments on mouse embryos and the vision of applying the observations and their insights in the embryo monitoring system using the AI and ML of SpOvum.

He had some wonderful questions and a few good suggestions and was appreciative of SpOvum’s initiative in bringing innovations to the A.R.T. space through Robotics, Automation, and AI.

From left to right: Kishor, Santosh, Dr. Keshav Malhotra, Ramnath, and Kunal

One-click immobilization feature of the RoboICSI workbench displayed on the screen

Demystifying Misconceptions about Infertility and conception using ART

World Health Organization (WHO) defines Infertility as Failure to achieve pregnancy after 12 months or more of regular unprotected sexual intercourse.

Here are some of the misconceptions about Infertility.

Myth 1: Treatment for Infertility is complex and expensive
It depends upon the condition of the patient. Depending upon the degree of the complexity of the situation different procedures like Ovulation Induction (OI), Intra Uterine Insemination (IUI), and Invitro fertilization (IVF) are available. The procedures need not be complex and expensive. Except for the case of IVF, others are out-patient treatments

Myth 2: Infertility is due to a female’s inability
On the contrary, males contribute significantly to infertility[1].

Myth 3: Infertility treatment assures success
Depending upon several aspects the success rate is estimated to be about 40% or more[2]

Myth 4: Infertility treatment is affordable only to the Rich
Indian medical eco-system is making conscious efforts in ensuring that the treatment is accessible and affordable without compromising on quality.

Myth 5: Infertility treatment can be taken at any age
While it seems to be true age plays a significant role in achieving success. The odds of success improve if one takes it at an earlier age.[3]

Let’s collaborate…

If you have questions or if you want to be a part of this myth-busting venture about infertility and conception using ART, you can reach out to contact@spovum.com or send a message on 9513646022

“If you or anyone you know need help in and around Bagalkote reach out to Mane Hospital’s LifeNu IVF Center. It is quite accessible and affordable. It is situated very close to both the Railway station as well the Bus Stand of Bagalkote. LifeNu in collaboration with SpOvum intends to bring the best in class ART technology to its patients!”

– LifeNu IVF Center, Mane Hospital

References:

  1. Kumar N, Singh AK. Trends of male factor infertility, an important cause of infertility: A review of literature. J Hum Reprod Sci. 2015 Oct-Dec;8(4):191-6. doi: 10.4103/0974-1208.170370. PMID: 26752853; PMCID: PMC4691969.https://pubmed.ncbi.nlm.nih.gov/26752853/
  2. Malhotra N, Shah D, Pai R, Pai HD, Bankar M. Assisted reproductive technology in India: A 3 year retrospective data analysis. J Hum Reprod Sci. 2013 Oct;6(4):235-40. doi: 10.4103/0974-1208.126286. PMID: 24672161; PMCID: PMC3963305.https://academic.oup.com/hropen/article/2017/2/hox011/4062213
  3. Megan L. Sneed, Meike L. Uhler, H. Edward Grotjan, John J. Rapisarda, Kevin J. Lederer, Angeline N. Beltsos, Body mass index: impact on IVF success appears age-related , Human Reproduction, Volume 23, Issue 8, 1 August 2008, Pages 1835–1839, https://doi.org/10.1093/humrep/den188



SpOvum at LifeNu

SpOvum has been operating successfully at Mane hospital’s LifeNU. While SpOvum is taking care of their operations including Technology-enablement, Embryologists, Dashboard, Maintenance, Calibration ad a bit of counseling. Recently SpOvum has also installed its flagship product- RoboICSI® holder, and smART Alerts system. SpOvum is making a conscious effort to see that LifeNU meets its KPIs along the Vienna consensus.

Largely, it has been successful in achieving so. For example, we have got an ICSI Damage rate of 0% (Benchmark from Vienna consensus is ≤ 5%), a Day3 Embryo Development rate of 84% (Benchmark from Vienna consensus is ≥ 70%), Blastocyst cryo survival rate of 100% (Benchmark from Vienna consensus is ≥ 99%)

SpOvum is making strides in ensuring IVF hospitals excel in providing quality IVF treatment to patients.

%d bloggers like this: